Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The key to swift treatments to cure the pain of rheumatoid arthritis has been found in the joints of people with the condition who are in long- term remission.

The study, published in Nature Medicine found that people with arthritis in long-term remission had a difference in cell function which could settle inflammation and 'teach' nearby cells to repair the joint.

Although treatment for rheumatoid arthritis has improved, some people with the condition do not respond well with many having unpredictable 'flare-ups' of the disease. Scientists now hope that by harnessing the benefit of these 'resolving' cells it could lead to new and more effective treatments.

The University of Glasgow led the study in collaboration with Fondazione A.Gemelli IRCCS in Italy and the Versus Arthritis funded Research into Inflammatory Arthritis Centre (RACE).

Professor Christopher Buckley, one of the RACE leaders and the Director of Clinical Research, Kennedy Institute of Rheumatology, University of Oxford said: "One of the holy grails in research into rheumatoid arthritis is how to help repair the joint. This is now a step closer as in this national collaboration (RACE) we have worked with colleagues in the Division of Rheumatology, and Fondazione A.Gemelli IRCCS to identify a key cell type that is missing and needs to be replenished in order to help patients who have active arthritis achieve remission of their disease. We hope that knowing more about this cell type will also allow us to predict when patients are like to have a flare in their disease."

The study looked at high resolution images of the joints of people with rheumatoid arthritis in long-term remission. The researchers found that the membrane that protects and lubricates their joints appeared normal, in contrast to the inflamed, swollen joints of severe arthritis.

The researchers found a crucial difference in the functions of cells called macrophages. In active arthritis these macrophages arrived from blood and caused inflammation and joint damage. People in long-term remission had a different type of macrophage that could resolve inflammation and instruct adjacent cells to repair the joint.

"The result of this study is a credit to the vision and teamwork of our multinational collaborators," said lead author Dr. Mariola Kurowska-Stolarska, from University of Glasgow and RACE. "We identified different types of macrophages, and our goal now is to discover treatments that will encourage development of resolving macrophages in the joint.

"This would be a useful additional strategy to current treatments that calm-down the aggressive macrophages in arthritis. In the meantime, the relative numbers of resolving macrophages or aggressive macrophages in the synovium, or joint, might be a good predictor of flare and an indicator of arthritis patients maintaining remission."

Similar stories

NIHR Fellowships awarded to NDORMS researchers

Congratulations to Eileen Morrow and Mae Chester-Jones who have received NIHR Doctoral Fellowships

ORUK Early Career Research Fellowship awarded to NDORMS researcher

Congratulations to Jack Tu who has been awarded an Orthopaedic Research UK Early Career Research Fellowship to explore the cause of knee pain after total knee replacement.

OCTRU - delivering answers to important clinical questions

The Oxford Clinical Trials Research Unit (OCTRU) has received NIHR benchmarking results and offers excellent value for money according to the report

Unhelpful thoughts about fracture symptoms hinder recovery

The importance of mindsets and feelings about fracture symptoms have been shown to be a key factor in recovery of musculoskeletal conditions.

Fat tissues can play a protective role against inflammation in the intestine

A new study in The EMBO Journal has revealed how fat tissues might provide a protective role in intestinal inflammation opening new lines of research into the treatment of inflammatory bowel diseases.

NDORMS researchers awarded Sir Henry Wellcome Fellowships

Kennedy Institute researchers Mariana Borsa and Edward Jenkins have both been awarded Sir Henry Wellcome Postdoctoral Fellowships, which give recently qualified postdoctoral researchers the opportunity to start independent research careers.